| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 152.36 KB | Adobe PDF |
Advisor(s)
Abstract(s)
According to the latest International Diabetes Federation 2015 report, the total health expenditure with type 2 diabetes (T2D) spent globally was of 673 billion USD in 2015 and it expected that this effort increases up to 802 billion in 2040. Additionally, patients experienced a series of complications, ranging from eye, cardiovascular, and kidney disease as well as pregnancy complications, nerve damage, foot infections and impaired regeneration. Based on the most recent research in this area the cornerstone of treatment of T2D is the adoption of a healthy diet, increased physical activity and maintenance of a normal body weight and those are modifiable risk factors.
Description
Keywords
Type 2 diabetes Early diagnosis biomarkers Point of care
Citation
Fernandes, R., Luís, C., Martins, P., Macedo, J. M., Guerreiro, S., & Baylina, P. (2019). BIO4DIA: Early detection and monitoring of metabolic progression of type 2 diabetes. Workshop on R&D Projects 2016, 15–17.